Prospective Attitudes towards Respiratory Syncytial Virus (RSV) Vaccination: Validation of a Survey Instrument among Young Females in Jordan Pending Vaccine Authorization

Prospective Attitudes towards Respiratory Syncytial Virus (RSV) Vaccination: Validation of a Survey Instrument among Young Females in Jordan Pending Vaccine Authorization

In May 2023, the U.S. FDA advisors endorsed Pfizer’s pregnancy-administered vaccine (branded ABRYSVO) to protect infants from respiratory syncytial virus (RSV) infection. Vaccination can reduce the burden of RSV-related respiratory disease, with previous studies showing its substantial medical and f...

Full description

Bibliographic Details
Main Authors: Tleen Kherfan, Malik Sallam
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Vaccines
Subjects:
vaccination perception
vaccine attitude assessment tool
vaccine rejection
respiratory virus
RSV
infants
Online Access:https://www.mdpi.com/2076-393X/11/8/1386

Internet

https://www.mdpi.com/2076-393X/11/8/1386

Similar Items